RecruitingNCT02139163

Epidemiological Study on Community Acquired Pneumonia

Sponsor

Capnetz Stiftung

Enrollment

20,000 participants

Start Date

Oct 1, 2002

Study Type

OBSERVATIONAL

Conditions

Community-acquired Pneumonia

Summary

The main objective of this study is to investigate prevalence and risk factors for community-acquired pneumonia (CAP) and its interaction with comorbidities in an unselected group of adult patients receiving outpatient and inpatient care. In addition, information on HIV as a risk factor for CAP and on CAP in immunocompromised patients is collected.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with community-acquired pneumonia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Medical School Hannover

Hanover, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02139163

Related Trials

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

NCT05722938154 locations

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL

NCT0613449228 locations

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

NCT071641315 locations

Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy

NCT0696631038 locations

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

NCT069968341 location